Cargando…
Why small particle fixed dose triple therapy? An excursus from COPD pathology to pharmacological treatment evolution
Although bronchodilators are the cornerstone in chronic obstructive pulmonary disease (COPD) therapy, the treatment with a single-agent bronchodilator may not provide adequate symptoms control in COPD. The combination of drugs with different mechanisms of action may be more effective in inducing bro...
Autores principales: | Braido, Fulvio, Corsico, Angelo G., Paleari, Davide, Piraino, Alessio, Cavalieri, Luca, Scichilone, Nicola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796083/ https://www.ncbi.nlm.nih.gov/pubmed/35044875 http://dx.doi.org/10.1177/17534666211066063 |
Ejemplares similares
-
Day and Night Control of COPD and Role of Pharmacotherapy: A Review
por: Braghiroli, Alberto, et al.
Publicado: (2020) -
Oxidative Stress and Respiratory System: Pharmacological and Clinical Reappraisal of N-Acetylcysteine
por: Santus, Pierachille, et al.
Publicado: (2014) -
Effects of aclidinium on determinants of COPD severity: symptoms and quality of life
por: Contoli, Marco, et al.
Publicado: (2016) -
LABA/LAMA fixed-dose combinations in patients with COPD: a systematic review
por: Rogliani, Paola, et al.
Publicado: (2018) -
Therapeutic Alliance and Outcome of Psychotherapy: Historical Excursus, Measurements, and Prospects for Research
por: Ardito, Rita B., et al.
Publicado: (2011)